Levetiracetam: A long-term follow-up study of efficacy and safety

Acta Neurologica Scandinavica

Volumn 114, Issue 3, 2006, Pages 169-176

  Bauer, J ^a,g   Ben Menachem, E ^b   Kramer G ^c   Fryze, W ^d   Da Silva, S ^e   Kasteleijn Nolst Trenite D G A ^f  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c SWISS EPILEPSY CENTER   (Switzerland)

^d Oddzial Neurologii   (Poland)

^e UCB PHARMA   (Belgium)

^f Location Alkmaar   (Netherlands)

^g UNIVERSITY OF BONN   (Germany)

Author keywords

Add on therapy; Antiepileptic drug; Epilepsy; Levetiracetam; Long term treatment; Seizure frequency

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; GAMMA GLUTAMYLTRANSFERASE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ANEMIA; ARTICLE; ASTHENIA; BRONCHITIS; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; CONVULSION; DISEASE EXACERBATION; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; EPILEPSY; EUROPE; FEMALE; FLU LIKE SYNDROME; FOCAL EPILEPSY; FOLLOW UP; FRACTURE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAND MAL SEIZURE; HUMAN; HYPERTENSION; HYPOTENSION; INFECTION; INJURY; LEUKOPENIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PHARYNGITIS; PRESCRIPTION; PROBABILITY; SEIZURE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PIRACETAM; TREATMENT OUTCOME;

EID: 33746872168     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00657.x     Document Type: Article

References (26)

1. REYNOLDS EH. ILAE/IBE/WHO Global Campaign "Out of the Shadows": global and regional developments. Epilepsia 2001;42:1094-100.
2. SCOTT RA, LLATOO SD, Sander Jwas. The treatment of epilepsy in developing countries: where do we go from here? BullWorld Health Organ 2001;79:344-51.
3. SCHMIDT D, LÖSCHER W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 2005;46:858-77.
4. BEGHI E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 2004;3:618-21.
5. ONAT F, OZKARA C. Adverse effects of new antiepileptic drugs. Drugs Today 2004;40:325-42.
6. MATTSON RH, CRAMER JA, COLLINS JF. Early tolerance to antiepileptic drug side effects: a controlled trial of 247 patients. In: Koella WP et al. , eds. Tolerance to beneficial and adverse effects of antiepileptic drugs. New York: Raven Press, 1986;149-56.
7. BEYDOUN A, SACHDEO RC, KUTLUAY E, MCCAGUE K, D'SOUZA J. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. Epilepsia 2003;44:1160-5.
8. KALVIAINEN R. Long-term safety of tiagabine. Epilepsia 2001;42:46-8.
9. ARVIO M, SILLANPAA M. Topiramate in long-term treatment of epilepsy in the intellectually disabled. J Intellect Disabil Res 2005;49:183-9.
10. BOOTSMA HP, COOLEN F, ALDENKAMP AP et al. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 2004;5:380-7.
11. ROSENFELD WE, SACHDEO RC, FAUGHT RE, PRIVITERA M. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment. Epilepsia 1997;38:S34-6.
12. TRENITE DG, RENTMEESTER TW, SCHOLTES FB, GILISSEN KG, ARENDS LR, SCHLOSSER A. Peri-marketing surveillance of lamotrigine in the Netherlands: doctors' and patients' viewpoints. Pharm World Sci 2001;23:1-5.
13. MACKAY FJ, WILTON LV, PEARCE GL, FREEMANTLE SN, MANN RD. Safety of long-term lamotrigine in epilepsy. Epilepsia 1997;38:881-6.
14. LHATOO SD, WONG IC, POLIZZI G, SANDER JW. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Epilepsia 2000;41:1592-6.
15. WONG IC, CHADWICK DW, FENWICK PB, MAWER GE, SANDER JW. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy. Epilepsia 1999;40:1439-45.
16. ALSAADI TM, SHATZEL A, MARQUEZ AV, JORGENSEN J, FARIAS S. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study. Seizure 2005;14:139-42.
17. BEN-MENACHEM E, EDRICH P, VAN VLEYMEN B, SANDER JWAS, SCHMIDT B. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Res 2003;53:57-64.
18. KRAKOW K, WALKER M, OTOUL C, SANDER JW. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 2001;56:1772-4.
19. SHORVON SD, VAN RIJCKEVORSEL K. A new antiepileptic drug. J Neurol Neurosurg Psychiatry 2002;72:426-9.
20. DUCHOWNY M, GILMAN J, MESSENHEIMER J, WOMBLE G, RISNER M, and the Lamictal Pediatric Study Group. Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy. J Child Neurol 2002;17:278-85.
21. SHORVON SD, LÖWENTHAL A, JANZ D, BIELEN E, LOISEAU P, for the European Levetiracetam Study Group. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000;41:1179-86.
22. CEREGHINO JJ, BITON V, ABOU-KHALIL B, DREIFUSS F, GAUER LJ, LEPPIK I, the United States Levetiracetam Study Group. Levetiracetam for partial seizures. Results of a double-blind, randomized clinical trial. Neurology 2000;55:236-42.
23. BEN-MENACHEM E, FALTER U for the European Levetiracetam Study Group. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia2000;41:1276-83.
24. BETTS T, WAEGEMANS T, CRAWFORD P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 2000;9:80-7.
25. NAKKEN KO, ERIKSSON A-S, LOSSIUS R, JOHANNESSEN SI. A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy. Seizure 2003;12:42-6.
26. SOMERVILLE ER. Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials? Neurology 2002;59:79-83.